TPST · Tempest Therapeutics Inc
United States · RS rating 4 · As of 2026-11-03
| Price | 0.47 USD |
|---|---|
| 1-day change | -0.7% |
| RS rating (overall / 1M / 3M / 12M) | 4 / 6 / 9 / 3 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 23 / 8 / 48 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +86.6% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +95.3% |
| Market cap (USD) | $25.8M |